China Enteral Feeding Formulas Market Size & Outlook
China enteral feeding formulas market, 2018-2030 (US$M)
Related Markets
China enteral feeding formulas market highlights
- The China enteral feeding formulas market generated a revenue of USD 723.4 million in 2023 and is expected to reach USD 1,128.9 million by 2030.
- The China market is expected to grow at a CAGR of 6.6% from 2024 to 2030.
- In terms of segment, oral was the largest revenue generating product in 2023.
- Oral is the most lucrative product segment registering the fastest growth during the forecast period.
Enteral feeding formulas market data book summary
| Market revenue in 2023 | USD 723.4 million |
| Market revenue in 2030 | USD 1,128.9 million |
| Growth rate | 6.6% (CAGR from 2023 to 2030) |
| Largest segment | Oral |
| Fastest growing segment | Oral |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oral, Enteral |
| Key market players worldwide | Abbott Laboratories, Danone SA, Fresenius SE & Co KGaA, Nestle SA, Meiji Holdings Co Ltd, Reckitt Benckiser Group PLC, Victus, Primus Pharmaceuticals |
Other key industry trends
- In terms of revenue, China accounted for 10.0% of the global enteral feeding formulas market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China enteral feeding formulas market is projected to lead the regional market in terms of revenue in 2030.
- Australia is the fastest growing regional market in Asia Pacific and is projected to reach USD 114.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Enteral Feeding Formulas Market Scope
Enteral Feeding Formulas Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China enteral feeding formulas market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to enteral feeding formulas market will help companies and investors design strategic landscapes.
Oral was the largest segment with a revenue share of 90.07% in 2023. Horizon Databook has segmented the China enteral feeding formulas market based on oral, enteral covering the revenue growth of each sub-segment from 2018 to 2030.
China enteral feeding formulas market is anticipated to witness lucrative growth over the forecast period due to increase in the geriatric population. According to a UN report, the elderly population will increase twofold from 10% in 2017 to 20% by 2037.
Rising geriatric population, increasing per capita healthcare expenditure, and growing prevalence of esophageal cancer are some of the major factors expected to propel the growth of enteral feeding formulas market in China.
For instance, as per the Global Cancer Observatory Report, around 307,359 new cases of esophageal cancer were reported in China in 2018. In such cases, enteral nutrition is required, which is likely to boost the enteral feeding formulas market in China.
Reasons to subscribe to China enteral feeding formulas market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China enteral feeding formulas market databook
-
Our clientele includes a mix of enteral feeding formulas market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China enteral feeding formulas market , including forecasts for subscribers. This country databook contains high-level insights into China enteral feeding formulas market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China enteral feeding formulas market size, by stage, 2018-2030 (US$M)
China Enteral Feeding Formulas Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
